Abivax (ABVX FP) spokesperson denies AstraZeneca's (AZN LN) takeover rumours
Context
The denial from Abivax regarding takeover rumors by AstraZeneca could temper speculation and volatility in both companies' stock prices. Since M&A rumors often drive market movement, this clarification reduces uncertainty but could also prompt traders to reassess valuation metrics and forecasts for possible future deals in the sector.
Trade the TapeGet this analysis live, the moment it breaksNewsquawk's real-time dashboard delivers market-moving headlines and instant context to your desk before the rest of the market reacts.
Open Dashboard#ASTRAZENECA PLC#AZN.LN#RUMOUR#EQUITIES#EU SESSION#US SESSION#PHARMACEUTICALS#PHARMACEUTICALS (GROUP)#PHARMACEUTICALS, BIOTECHNOLOGY & LIFE SCIENCES#EUROPEAN EQUITIES